Bio-informatics approaches in liver disease: Incomplete without experimental validation

<p>In the search for the treatment of hepatic diseases, multiple approaches have been used frequently such as bioinformatics and algorithm-based systems biology for the screening of already published data that leads to the identification of promising drug candidates at molecular levels. These...

Full description

Saved in:
Bibliographic Details
Main Author: Pratibha Gaur (Author)
Format: Book
Published: Archives of Hepatitis Research - Peertechz Publications, 2022-09-27.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000 am a22000003u 4500
001 peertech__10_17352_ahr_000033
042 |a dc 
100 1 0 |a Pratibha Gaur  |e author 
245 0 0 |a Bio-informatics approaches in liver disease: Incomplete without experimental validation 
260 |b Archives of Hepatitis Research - Peertechz Publications,   |c 2022-09-27. 
520 |a <p>In the search for the treatment of hepatic diseases, multiple approaches have been used frequently such as bioinformatics and algorithm-based systems biology for the screening of already published data that leads to the identification of promising drug candidates at molecular levels. These studies provide a large data set of information and claim to identify many genes, which could be targeted for the cure. However, it is important to note that the identified compounds are only predictions and the potential of these suggested molecules or genes should be well confirmed by adopting robust and critical experimental approaches to satisfy all possible aspects to use them safely for therapeutic purposes. Therefore, I put forward the opinion that these predicted markers whether prognostic, diagnostic, or molecular must be evaluated critically through a well-defined experimental pipeline.</p> 
540 |a Copyright © Pratibha Gaur et al. 
546 |a en 
655 7 |a Opinion  |2 local 
856 4 1 |u https://doi.org/10.17352/ahr.000033  |z Connect to this object online.